Genmab — Juni 2012
-
14 dage gammel artikel, men dog interessant for Genmab: http://www.bloomberg.com/news/2012-05-23/glaxo-avoids-market-for-lemons-by-acquiring-its-collaborators.html
-
http://myeloma.org/ArticlePage.action?articleId=3707 om Daratumumab. Meget spændende
-
man skal en time og nogle minutter ind i den som også står skrevet i debatten 32 min fra slutningen
-
carnegie fik taget en del igen idag 32K netto.
-
og Credit agricole og enskilda er også med i kampen
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind